Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction

NCT02070549 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

NIH

Sponsor class

Conditions

Advanced Malignant Solid Neoplasm
Metastatic Malignant Neoplasm in the Liver
Metastatic Malignant Solid Neoplasm
Unresectable Solid Neoplasm

Interventions

DRUG: Trametinib

Sponsor

National Cancer Institute (NCI)